Kumail Waljee News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Kumail Waljee. Real-time updates on events, politics, business and more.

Syncona : OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board -September 27, 2023 at 04:52 am EDT

September 27, 2023

OMass Therapeutics , a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the...

United States United Kingdom Dame Carol Robinson Mark Namchuk Rosamond Deegan Ali Jazayeri

Source: marketscreener.com

OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases

April 28, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United States New York United Kingdom Mountain View City Of San Francisco

Source: apnews.com

OMass's OdyssION™ Drug Discovery Platform Makes Progress in Drugging the Undruggable, including Gasdermin D

February 28, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United Kingdom Dame Carol Robinson Rosamond Deegan Omass Odyss Oxford Science Enterprises Consilium Strategic Communications

Source: apnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Kumail Waljee News Today

Syncona : OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board -September 27, 2023 at 04:52 am EDT

OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases

OMass's OdyssION&#x2122; Drug Discovery Platform Makes Progress in Drugging the Undruggable, including Gasdermin D

Explore More Categories

OMass's OdyssION™ Drug Discovery Platform Makes Progress in Drugging the Undruggable, including Gasdermin D